Wegovy Pill Still Dominating GLP-1 Market, Analysts Say
Wegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
Zero Based Budgeting Strategies For Variable Income presents practical tactics to budget around fluctuating earnings and protect finances.
21,878 articlesWegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
Bitcoin trades near the $63,000 level as a new AI forecast from Microsoft Copilot outlines a 30-day path with a key r...
Investors are weighing Nvidia's aggressive capital return plans against the durability of its margins and evolving to...
A large open-market sale by Indivior's Chief Scientific Officer sparked questions about future risk and long-term val...
Trump’s truth social stake has fallen sharply while his golf properties surge, illustrating a two-track fortune in 2026.
A Parabilis Medicines director recently disclosed a substantial stake just after the company’s fresh IPO. This articl...
Memory-chip demand remains tight, and Micron's product mix positions it to benefit from AI adoption in data centers. ...
Nokia’s latest move isn't about handsets—it's about AI-friendly data-center networks. The Nokia acquired Infinera qui...
A new wave of enterprise chip investments is shaking up the AI hardware landscape. This huge news broadcom stock deve...
Elon Musk publicly weighs in on Mackenzie Scott’s $26 billion giving, sparking a larger debate about the effectivenes...
A little-known small-cap ETF is turning heads with bold gains in 2026. This guide explains what’s driving the perform...
When a chief financial officer sells a large block of stock, investors sit up and take notice. This article breaks do...